{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to msk.org
Memorial Sloan Kettering Cancer Center
  • Sign In
  • Live Courses
  • On Demand eLearning
  • Coming Soon
  • Visiting Us
  • About
  • Resources & Policies
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Select a button below to sign in or create an account. If you have previously registered or attended a MSK CME event, please sign in using the username and password created at course registration. MSK employees must use their SSO credentials to sign in. 

Single Sign On (MSK Employees)
Sign in or Create an Account
Enter your email and password to login:

*
*
Login

New to Memorial Sloan Kettering Cancer Center? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ACHPN
  • ACNP
  • ACNP-BC
  • AGACNP
  • AGACNP-BC
  • AGCNS
  • AGNP
  • AGNP-BC
  • ANP
  • ANP-BC
  • AS
  • AT
  • AuD
  • BA
  • BAO
  • BCC
  • BCh
  • Bchir
  • BM
  • BS
  • BS, MS
  • BSN
  • BSN, MS
  • BSN, MS, DNP
  • CCC-SLP
  • CCLS
  • CCRN
  • CCRP
  • CEN
  • ChB
  • CIPS
  • CNM
  • CNP
  • CPNP
  • CPNP-AC
  • CRNA
  • CRNP
  • CTTS
  • D(ABMM)
  • DAc
  • DACM
  • DAHM
  • DAOM
  • DDS
  • DDS, MPH
  • DMD
  • DMD, PhD
  • DNB
  • DNP
  • DNP, RN
  • DNSc
  • DO
  • DPM
  • DPM
  • DPT
  • DrPH
  • DSc
  • DVM
  • EdD
  • EdS
  • FAAP
  • FACNM
  • FACOG
  • FACS
  • FASCRS
  • FASN
  • FCCM
  • FCCP
  • FIPP
  • FNP
  • FNP-BC
  • GNP
  • GNP-BC
  • HUC
  • JD
  • LAc
  • LCSW
  • LISW
  • LISW-S
  • LMSW
  • LPCC
  • LPN
  • LSW
  • MA
  • MAc
  • MAcOM
  • MB
  • MB, PhD
  • MBA
  • MBBCh
  • MBBCh BAO
  • MBBCh BAO, PhD
  • MBBCh, MPH
  • MBBCh, PhD
  • MBBS
  • MBBS, MPH
  • MBBS, PhD
  • MBChB
  • MD
  • MD, DSc
  • MD, FCCP
  • MD, FCCP, DAABIP
  • MD, JD
  • MD, MA
  • MD, MAS
  • MD, MBA
  • MD, MHA
  • MD, MPH
  • MD, MPH, MHS
  • MD, MS
  • MD, MS, PhD
  • MD, PhD
  • MD, PhD, MA
  • MD, PhD, MPH
  • MD, PhD, MS
  • MDiv
  • MDS
  • MEd
  • MHS
  • MPA
  • MPH
  • MPhil
  • MS
  • MSc
  • MSc, PhD
  • MSN
  • MSPH
  • NCTTP
  • None
  • NP
  • NP, RN
  • OCN
  • OD
  • Other
  • OTR
  • PA
  • PA-C
  • PCA
  • PharmD
  • PharmD, PhD
  • PhD
  • PhD, MBA, MS
  • PhD, MPH
  • PhD, MPhil
  • PhD, MS
  • PhD, MSc
  • PhD, NP, RN
  • PsyD
  • PT
  • RA
  • RCS
  • RD
  • RDCS
  • RDMS
  • RN
  • RN-BC
  • RPh
  • RRT
  • RT
  • ScD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

5th Annual MSK Symposium on Lymphoma


5th Annual MSK Symposium on Lymphoma Banner

  • Overview
  • Brochure
  • Faculty
  • Schedule
  • Sponsors
Add to Calendar 5th Annual MSK Symposium on Lymphoma 5/14/2021 9:45:00 AM 5/15/2021 12:40:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/Lymphoma2021 Description: This symposium will feature updated information on lymphoma biology, diagnosis, and ongoing efforts to translate the scientific discoveries into novel treatment strategies for a variety of lymphoma subtypes. This year, we will have a particular focus on the recent treatment options developed for patients with relapsed or refractory disease. Faculty will present those and then discuss during a panel how to best approach p... Online false MM/DD/YYYY


Date & Location
Friday, May 14, 2021, 9:45 AM - Saturday, May 15, 2021, 12:40 PM

Specialties
Specialties - Bone Marrow Transplant, Hematology, Immunotherapy, Internal Medicine, Molecular Biology, Nuclear Medicine, Oncology and Hematology, Pathology, Radiation Oncology

Overview

This symposium will feature updated information on lymphoma biology, diagnosis, and ongoing efforts to translate the scientific discoveries into novel treatment strategies for a variety of lymphoma subtypes. This year, we will have a particular focus on the recent treatment options developed for patients with relapsed or refractory disease. Faculty will present those and then discuss during a panel how to best approach patients' situation. We will also cover in a special session recent advances in the biology of lymphoma and how this will translate to innovative therapeutic interventions. Participants will have the opportunity to discuss diagnostic and management cases, and how to incorporate biomarkers and imaging into clinical practice and clinical trials.

Watch a brief welcome video from Gilles Salles, MD, PhD, MSK Course Director and Chief of the Lymphoma Service:

Who Should Attend

The target audience for this symposium includes medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in diagnosis, treatment, and biomedical research of lymphoma.

Live Virtual Format

This live virtual program will be delivered using Zoom. We encourage all attendees to download the Zoom app prior to the start of the course (zoom.us/download). CME credit will be offered for this live virtual program. Detailed access and credit instructions will be emailed to attendees prior to the start of the course.

Objectives
  1. provide up-to-date information on recent treatment options for patients with Hodgkin and non-Hodgkin lymphoma
  2. provide up-to-date information on recent updates for lymphoma imaging and pathology
  3. provide up-to-date information on innovative avenues for therapeutic interventions

Registration

Virtual Registration Fees

  • Physicians (MDs, PhDs and DOs): $200
  • Nurses, PAs and Other Healthcare Professionals: $50
  • Residents and Fellows: $50
  • Industry Professionals*: $350

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Discounts/Promotions

  • A registration discount is available for MSK Alumni, MSK Cancer Alliance, and Cancer Care Partners to attend a MSK CME course. If you are a member of one of these groups, contact [email protected] for details.
  • Registration is complimentary for all MSK employees; however, you must complete registration through the 'Register' tab above in order to attend this course. If you are registered for this course and are unable to attend, please notify [email protected].

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

Online Registration Deadline 

Online registration is available on the MSK CME Portal until 8:00 AM on May 14, 2021. If you wish to register after this date, please email [email protected] and we will ensure your registration is processed as well as access instructions are emailed to you prior to the start of the course. 

Cancellation Policy

If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity



Keywords:

MSK Course Director 

Gilles Salles, MD, PhD
Chief, Lymphoma Service 

 

MSK Planning Committee 

Ahmet Dogan, MD, PhD
Chief, Hematopathology Service
Departments of Pathology and Laboratory Medicine

Steven Horwitz, MD
Medical Oncologist

Andrew Intlekofer, MD
Assistant Member, Human Oncology & Pathogenesis Program

Ariela Noy, MD
Medical Oncologist

Hans-Guido Wendel, MD
Member/Professor, Cancer Biology & Genetics Program

Joachim Yahalom, MD
Radiation Oncologist

Andrew D. Zelenetz, MD, PhD 
Medical Director, Quality Informatics

 

Keynote Speakers 

Michel Sadelain, MD, PhD
Director, Center for Cell Engineering;
Stephen and Barbara Friedman Chair
Memorial Sloan Kettering Cancer Center
New York, NY

David Weinstock, MD
Lavine Family Chair for 
Preventative Cancer Therapies
Dana-Farber Cancer Institute
Boston, MA

 

Invited Course Faculty 

Philippe Armand, MD, PhD
Chief, Division of Lymphoma
Dana-Farber Cancer Institute
Boston, MA

Kivanç Birsoy, PhD
Chapman Perelman Assistant Professor
Rockefeller University
New York, NY

Martin Dreyling, MD, PhD
Professor of Medicine
University of Munich
Munich, Germany

Markus Müschen, MD, PhD
Arthur H. and Isabel Bunker 
Professor of Medicine (Hematology)
Director, Center of Molecular and Cellular Oncology 
Yale School of Medicine 
New Haven, CT

Gregor S. Nowakowski, MD
Consultant, Division of Hematology 
Department of Internal Medicine
Mayo Clinic 
Rochester, Minnesota

Simon Rule, MD, PhD
Professor in Haematology
Plymouth University Medical School
Plymouth, UK

 

MSK Course Faculty

Caleb Ho, MD
Pathologist

Anita Kumar, MD
Regional Care Network 
Medical Site Director, MSK Basking Ridge

Alison Moskowitz, MD
Clinical Director, Lymphoma Inpatient Unit

M. Lia Palomba, MD
Medical Oncologist

Craig Sauter, MD
Clinical Director, Adult Bone Marrow Transplant Service

Heiko Schoder, MD, MBA
Chief, Molecular Imaging and Therapy Service

 

Faculty Disclosures (All Faculty)

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Gilles Salles, MD, PhD
MSK
Activity Director, Faculty
Consulting Fee-Abbvie|Consulting Fee-Beigene|Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Debiopharm|Consulting Fee-Genmab|Consulting Fee-Gilead|Consulting Fee-Janssen|Consulting Fee-Milteniy|Consulting Fee-Morphosys|Consulting Fee-Novartis AG|Consulting Fee-Roche|Consulting Fee-Velosbio|Consulting Fee-IPSEN|Consulting Fee-Incyte
Andrew Intlekofer, MD
MSK
Conflict of Interest Peer Reviewer, Faculty, Planner
Nothing to disclose
Joachim Yahalom, MD, FACR, FASTRO
MSK
Conflict of Interest Peer Reviewer, Faculty, Planner
Nothing to disclose
Philippe Armand, MD
Dana-Farber Cancer Institute
Faculty
Consulting Fee-Bristol-Myers Squib Aventis|Consulting Fee-Merck and Company, Inc.|Consulting Fee-ADC Therapeutics|Consulting Fee-Regeneron|Consulting Fee-Genentech, Inc.|Consulting Fee-GenMab|Consulting Fee-Epizyme|Consulting Fee-Enterome|Consulting Fee-AstraZeneca
Kivanc Birsoy, PhD
Rockefeller University
Faculty
Consulting Fee-Barer Institute
Martin Dreyling , MD
University of Munich
Germany
Faculty
Contracted Research-Abbvie|Contracted Research-Bayer Corporation|Contracted Research-Celgene|Contracted Research-Janssen|Contracted Research-Roche|Speakers Bureau-Amgen|Speakers Bureau-AstraZeneca|Speakers Bureau-Bayer Corporation|Speakers Bureau-Celgene|Speakers Bureau-Gilead|Speakers Bureau-Janssen|Speakers Bureau-Roche|Consulting Fee-AstraZeneca|Consulting Fee-Bayer Corporation|Consulting Fee-Beigene|Consulting Fee-Celgene|Consulting Fee-Genmab|Consulting Fee-Gilead|Consulting Fee-Incyte|Consulting Fee-Janssen|Consulting Fee-Novartis AG|Consulting Fee-Roche
Caleb Ho, MD
MSK
Faculty
Honorarium-Invivoscribe, Inc
Anita Kumar, MD
MSK
Faculty
Nothing to disclose
Alison Moskowitz, MD
MSK
Faculty
Consulting Fee-Seattle Genetics|Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Kyowa Hakko Kirin Pharma|Consulting Fee-Miragen Therapeutics|Consulting Fee-Takeda Pharmaceuticals, Inc.|Consulting Fee-ADC Therapeutics|Contracted Research-Seattle Genetics|Contracted Research-Merck and Company, Inc.|Contracted Research-Bristol-Myers Squibb|Contracted Research-Incyte
Markus Müschen, MD, PhD
Yale Cancer Center
Faculty
Nothing to disclose
Gregor S. S Nowakowski, MD
Mayo Clinic
Faculty
Consulting Fee-MorphoSys |Consulting Fee-Incyte |Consulting Fee-Bristol-Myers Squibb|Contracted Research-Bristol-Myers Squibb|Consulting Fee-Ryvu |Contracted Research-Nanostrigs |Consulting Fee-Blueprint |Consulting Fee-TG Therapeutics |Consulting Fee-Kymera |Consulting Fee-Bantam Pharma |Consulting Fee-Roche
Maria Lia Palomba, MD
MSK
Faculty
Royalty-Juno
Simon Rule, MD, PhD
Plymouth University Medical School
Canada
Faculty
Fees for Non-CE Services Received Directly from a Commercial Interest or its Agent-Pharmacyclics, Inc.|Salary-VelosBio
Michel Sadelain, MD, PhD, Director
MSK
Faculty
Contracted Research-Fateh Therapeutics, Takeda Pharmaceuticals, and Atara Biotherapeutics
Craig S Sauter, MD
MSK
Faculty
Consulting Fee-Sanofi-Aventis|Consulting Fee-GlaxoSmithKline|Consulting Fee-Novartis AG|Consulting Fee-Gamida Cell|Contracted Research-Juno Therapeutics|Contracted Research-Sanofi-Aventis|Consulting Fee-Gilead|Consulting Fee-Precision Biosciences|Contracted Research-Precision Biosciences
Heiko Schoder, MD
MSK
Faculty
Nothing to disclose
David Weinstock, MD
Dana-Farber Cancer Institute
Faculty
Consulting Fee-Secura Bio|Consulting Fee-Expert witness-AstraZeneca|Contracted Research-Daiichi Sankyo|Contracted Research-Verastem|Consulting Fee-Bantam|Ownership Interest-Ajax|Ownership Interest-Travera
Ahmet Dogan, MD
MSK
Faculty, Planner
Consulting Fee-Peer Review Institute|Contracted Research-Roche|Contracted Research-Takeda|Consulting Fee-Physicians' Education Resource|Consulting Fee-LOXO ONCOLOGY
Steven Horwitz, MD
MSK
Faculty, Planner
Consulting Fee-Takeda Pharmaceuticals, Inc.|Consulting Fee-C4|Consulting Fee-myeloid|Consulting Fee-vividion|Consulting Fee-Ono|Consulting Fee-Acrotech|Consulting Fee-Trillium|Contracted Research-Daiichi Sankyo|Consulting Fee-Kyowa|Consulting Fee-seattle genetics|Contracted Research-Takeda Pharmaceuticals, Inc.|Contracted Research-seattle genetics|Contracted Research-ADCT Therapeutics|Contracted Research-trillium|Contracted Research-verastem, secura bio|Contracted Research-Affimed
Ariela Noy, MD
MSK
Faculty, Planner
Consulting Fee-Pharmacyclics, Inc.|Contracted Research-Pharmacyclics, Inc.|Consulting Fee-Morphosys|Consulting Fee-janssen|Contracted Research-raphael pharma|Consulting Fee-EUSA
Hans-Guido Wendel, MD
MSK
Faculty, Planner
Nothing to disclose
Andrew D Zelenetz, MD, PhD
MSK
Faculty, Planner
Consulting Fee-Genentech, Inc.|Contracted Research-Genentech, Inc.|Consulting Fee-Roche|Contracted Research-Roche|Consulting Fee-BMS/Celegene/Juno|Consulting Fee-Gilead|Consulting Fee-Amgen|Consulting Fee-Morphosys|Consulting Fee-Novartis AG|Consulting Fee-Adaptive Biotechnologies|Contracted Research-Adaptive Biotechnology|Contracted Research-Beigene|Consulting Fee-Beigene|Contracted Research-Boston Gene|Consulting Fee-MEI Pharmaceuticals|Contracted Research-MEI Pharmaceuticals|Consulting Fee-AstraZeneca
Shenon Sethi, MD
MSK
Resident/Fellow Planner
Nothing to disclose
Beatriz Wills, MD
FSFB
Resident/Fellow Planner
Nothing to disclose

Friday, May 14, 2021
SYLLABUS DISCLAIMER
9:45AM - 9:55AM

Please note only the presentations and videos from faculty that have given their consent will be available below.


Disclosures
9:55AM - 10:00AM
Metabolic and Epigenetic Cooperativity in T Cell Lymphoma
10:05AM - 10:20AM
Andrew Intlekofer, MD
Understanding the Role of Oxidative Metabolism in Blood Cancers
10:20AM - 10:35AM
Kivanc Birsoy, PhD
Connecting the Dots: The Link Between Serine Metabolism and Lymphoma Epigenetics
10:35AM - 10:55AM
Hans-Guido Wendel, MD
Mechanisms of B-cell Selection as Therapeutic Targets in Pre-GC Lymphomas
10:55AM - 11:10AM
Markus Müschen, MD, PhD
Starving Lymphoma Cells Panel Discussion: Q&A
11:10AM - 11:25AM
PET-CT in HL: Recent Insights
11:25AM - 11:45AM
Heiko Schoder, MD
Can ASCT be Avoided in Relapsed HL
11:45AM - 12:00PM
Alison Moskowitz, MD
ASCT & Cellular Therapies in HL
12:00PM - 12:15PM
Philippe Armand, MD
Hodgkin Lymphoma (HL) Panel Discussion: Q&A
12:15PM - 12:25PM
New Vulnerabilities in T-cell Lymphomas
12:25PM - 12:55PM
David Weinstock, MD
Saturday, May 15, 2021
DLBCL Pathology: New Insights
9:00AM - 9:10AM
Ahmet Dogan, MD
Positioning CAR-T in Relapsed / Refractory DLBCL
9:10AM - 9:30AM
Craig S Sauter, MD
Effective and Off the Shelf – New Agents in Relapsed and Refractory DLBCL
9:30AM - 9:50AM
Gregor S. S Nowakowski, MD
Diffuse Large B-cell Lymphoma (DLBCL) Panel Discussion: Q&A
9:50AM - 10:05AM
MCL Pathology: New Insights
10:05AM - 10:15AM
Caleb Ho, MD
Targeted Therapies in MCL
10:15AM - 10:30AM
Simon Rule, MD, PhD
CAR-T in R/R MCL
10:30AM - 10:45AM
Maria Lia Palomba, MD
Mantle Cell Lymphoma Panel Discussion: Q&A
10:45AM - 11:00AM
Less is More: New RT Paradigm for Indolent Lymphomas
11:05AM - 11:20AM
Joachim Yahalom, MD, FACR, FASTRO
Managing Early Relapses in FL: The Role of Chemotherapy
11:20AM - 11:35AM
Martin Dreyling , MD
Management of Early Relapses: New Agents
11:35AM - 11:50AM
Gilles Salles, MD, PhD
Follicular Lymphoma (FL) Panel Discussion: Q&A
11:50AM - 12:05PM
Lessons from CD19 CAR Therapy
12:05PM - 12:35PM
Michel Sadelain, MD, PhD, Director

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants for this live activity:

AstraZeneca
Bristol Myers Squibb
Janssen Research & Development, LLC 


CME Courses

Live Courses
On Demand eLearning
Coming Soon

Resources & Policies

CME Program Terms of Use
Registration Discounts
Cancellation Policy
Industry Professionals

Attendee & Faculty Information

My CME / Attendee Resources
Claim RSS Credit (MSK Staff)
Faculty Disclosure Form
Faculty Tasks Page

Connect

Locations & Visitor Info
Help / Contact Us
Subscribe to CME Announcements




MSK CME

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

©2026 Memorial Sloan Kettering Cancer Center